Grape King Bio Ltd (TPE:1707)
124.50
+0.50 (0.40%)
Oct 23, 2025, 2:36 PM CST
Grape King Bio Revenue
Grape King Bio had revenue of 2.57B TWD in the quarter ending June 30, 2025, a decrease of -6.86%. This brings the company's revenue in the last twelve months to 10.88B, up 0.17% year-over-year. In the year 2024, Grape King Bio had annual revenue of 11.16B with 4.93% growth.
Revenue (ttm)
10.88B
Revenue Growth
+0.17%
P/S Ratio
1.70
Revenue / Employee
21.71M
Employees
501
Market Cap
18.44B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 11.16B | 524.54M | 4.93% |
| Dec 31, 2023 | 10.64B | 244.23M | 2.35% |
| Dec 31, 2022 | 10.39B | 592.99M | 6.05% |
| Dec 31, 2021 | 9.80B | 630.05M | 6.87% |
| Dec 31, 2020 | 9.17B | -70.88M | -0.77% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Bora Pharmaceuticals Co., LTD. | 21.32B |
| Lotus Pharmaceutical | 19.12B |
| PharmaEssentia | 12.63B |
| Pegavision | 6.67B |
| Sunmax Biotechnology | 1.95B |
| Center Laboratories | 1.60B |
| Oneness Biotech | 112.57M |
| Polaris Group | 64.02M |